Significance of tissue laminin P1 elastase and fibronectin levels in transitional cell carcinoma of the bladder

被引:19
作者
Kirkali, G
Tüzel, E
Güler, C
Gezer, S
Kirkali, Z [1 ]
机构
[1] Dohuz Eylul Univ, Sch Med, Dept Urol, TR-35340 Izmir, Turkey
[2] Dohuz Eylul Univ, Sch Med, Dept Urol, TR-35340 Izmir, Turkey
关键词
bladder; transitional cell carcinoma; laminin P-1; fibronectin; elastase; prognostic markers;
D O I
10.1159/000052456
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: Elastase is a serine protease which hydrolyses connective tissue components. Laminin and fibronectin also play an important role in progression and invasion of cancer. The purpose of this study is to investigate the relation between tissue elastase, laminin P-1 and fibronectin levels and tumor characteristics, and analyze the potential of these as prognostic factors in transitional cell carcinoma (TCC) of the bladder. Methods: Thirty-four patients with TCC of the bladder and 11 controls were included in this study. Elastase and fibronectin levels in tissue homogenates were determined using an enzyme immunoassay and laminin P-1 by radioimmunoassay. Mean follow-up was 43 months. Results: The mean elastase level in bladder carcinoma tissue was 120 +/- 11.42 ng/homogenate protein, while normal tissue level was 12.36 +/-2.70 (p<0.01). The carcinoma and normal tissue mean laminin P-1 levels were 7.02<plus/minus>0.37 U and 0.65 +/-0.10 U/mg homogenate protein, respectively (p<0.01). The mean fibronectin level was 19.97<plus/minus>1.45 ng/mg homogenate protein in the carcinoma tissue and 2.16 +/-0.40 in normal tissue (p<0.01). There was no correlation between tumor stage, grade, size, multiplicity and elastase, laminin P-1 and fibronectin levels. Conclusion: These results provide evidence that tissue elastase, laminin P-1 and fibronectin levels increase in TCC of the human bladder. Further studies including serum and urine levels should be performed in order to analyze their value as tumor markers in a larger group of patients. Copyright <(c)> 2001 S. Karger AG, Basel.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [21] URINARY INTERLEUKIN-1-ALPHA LEVELS ARE INCREASED BY INTRAVESICAL INSTILLATION WITH KEYHOLE LIMPET HEMOCYANIN IN PATIENTS WITH SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
    JURINCICWINKLER, CD
    GALLATI, H
    ALVAREZMON, M
    SIPPEL, J
    CARBALLIDO, J
    KLIPPEL, KF
    EUROPEAN UROLOGY, 1995, 28 (04) : 334 - 339
  • [22] Management of bladder transitional cell carcinoma in stage T1G3
    Mustafa, Mahmoud
    Barakat, Tamer S.
    Ali-El-Edein, Bedier
    TURKISH JOURNAL OF UROLOGY, 2010, 36 (02): : 119 - 124
  • [23] Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder
    Nakagawa, T
    Kanai, Y
    Saito, Y
    Kitamura, T
    Kakizoe, T
    Hirohashi, S
    JOURNAL OF UROLOGY, 2003, 170 (06) : 2463 - 2466
  • [24] The management of stage T1 grade 3 transitional cell carcinoma of the bladder
    Evans, CP
    Busby, JE
    BJU INTERNATIONAL, 2003, 92 (04) : 345 - 348
  • [25] Prognostic significance of hepatoma-up-regulated protein expression in patients with urinary bladder transitional cell carcinoma
    Huang, YL
    Chiu, AW
    Huan, SK
    Wang, YC
    Ju, JP
    Lu, CL
    ANTICANCER RESEARCH, 2003, 23 (3B) : 2729 - 2733
  • [26] Expression and Prognostic Significance of Bcl-2 and Bax in The Progression and Clinical Outcome of Transitional Bladder Cell Carcinoma
    Eimani, Bahram Golestani
    Sanati, Mohammad Hossein
    Houshmand, Masoud
    Ataie, Mitra
    Akbarian, Fatemeh
    Shakhssalim, Naser
    CELL JOURNAL, 2014, 15 (04) : 356 - 363
  • [27] Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder
    Savic-Radojevic, Ana
    Mimic-Oka, Jasmina
    Pljesa-Ercegovac, Marija
    Opacic, Marija
    Dragicevic, Dejan
    Kravic, Tamara
    Djokic, Milan
    Micic, Sava
    Simic, Tatjana
    EUROPEAN UROLOGY, 2007, 52 (02) : 470 - 477
  • [28] Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma
    Tiguert, R
    Bianco, FJ
    Oskanian, P
    Li, YW
    Grignon, DJ
    Wood, DP
    Pontes, JE
    Sarkar, FH
    JOURNAL OF UROLOGY, 2001, 166 (06) : 2155 - 2160
  • [29] Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder
    Shariat, SF
    Kim, JH
    Ayala, GE
    Kho, K
    Wheeler, TM
    Lerner, SP
    JOURNAL OF UROLOGY, 2003, 169 (03) : 938 - 942
  • [30] Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder
    Shariat, SF
    Herman, MP
    Casella, R
    Lotan, Y
    Karam, JA
    Stenman, UH
    EUROPEAN UROLOGY, 2005, 48 (03) : 424 - 431